This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción ACST
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Acasti Pharma Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.58 |
| 52 Week High | CA$1.66 |
| 52 Week Low | CA$0.47 |
| Beta | 1.22 |
| 1 Month Change | -27.50% |
| 3 Month Change | -17.14% |
| 1 Year Change | -62.82% |
| 3 Year Change | -83.89% |
| 5 Year Change | -94.86% |
| Change since IPO | -98.87% |
Noticias y actualizaciones recientes
Rentabilidad de los accionistas
| ACST | CA Pharmaceuticals | Mercado CA | |
|---|---|---|---|
| 7D | -6.5% | 8.0% | -0.2% |
| 1Y | -62.8% | 48.0% | 6.1% |
Rentabilidad vs. Industria: ACST exceeded the Canadian Pharmaceuticals industry which returned -65.4% over the past year.
Rentabilidad vs. Mercado: ACST underperformed the Canadian Market which returned -11.9% over the past year.
Volatilidad de los precios
| ACST volatility | |
|---|---|
| ACST Average Weekly Movement | 15.5% |
| Pharmaceuticals Industry Average Movement | 14.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Precio estable de las acciones: ACST's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: ACST's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2002 | n/a | Jan D'Alvise | www.acastipharma.com |
Resumen de fundamentos de Acasti Pharma Inc.
| Estadísticas fundamentales de ACST | |
|---|---|
| Capitalización bursátil | CA$19.23m |
| Beneficios(TTM) | -CA$23.45m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-1.1x
Ratio precio-beneficio (PE)¿Está ACST sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ACST | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | US$17.25m |
| Beneficios | -US$17.25m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.39 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado ACST a largo plazo?
Ver rendimiento histórico y comparativa